• Je něco špatně v tomto záznamu ?

Anxiety in Patients with Post-COVID Syndrome: Associated Factors

J. Bocek, D. Kamaradova Koncelikova, J. Vanek, K. Latalova, S. Genzor, J. Mizera

. 2024 ; 17 (-) : 3255-3265. [pub] 20240920

Status neindexováno Jazyk angličtina Země Nový Zéland

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24017778

INTRODUCTION: The term "post-COVID-19 syndrome" describes a range of symptoms persisting beyond the acute phase of the disease. These symptoms predominantly include fatigue, muscle pain, shortness of breath, and psychological issues. Research additionally suggests the possibility of long-term neurological and psychiatric impairment associated with COVID-19. METHODOLOGY: The study included patients who visited the post-COVID outpatient clinic between April 2020 and June 2022. The examination included the detailed history taking, including the COVID-19 course, posteroanterior chest X-ray and pulmonary function tests. Anxiety level was assessed using the Beck Anxiety Inventory (BAI). The relationship between anxiety, demographic data, and course of the disease, need for hospital admission during the acute phase, oxygen therapy, post-inflammatory changes on the chest X-ray and lung function parameters was investigated. RESULTS: This study included 1756 patients who experienced COVID-19 and visited a post-COVID outpatient clinic. The majority of individuals experienced a mild form of the infection. The results showed that younger age and female gender were associated with significantly higher anxiety scores. Inpatients had lower BAI values than those who were not hospitalized during acute phase. Patients with post-inflammatory changes on chest X-ray had surprisingly lower BAI values. Lower values of FEV1 (forced expiratory volume in 1 second), DLCO (diffusing capacity of the lungs for carbon monoxide), and KCO (carbon monoxide transfer coefficient) were associated with significantly higher BAI values. Female gender was associated with higher levels of anxiety. In contrast, higher FEV1 values reduced the risk of a pathological level of anxiety. CONCLUSION: In our study, the influence of age, gender, inpatient care during the acute phase of infection, the presence of post-inflammatory changes on the chest diagram and selected parameters of lung function (FEV1, DLCO, and KCO) were shown to be important factors in the assessment of anxiety symptoms in post-COVID patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24017778
003      
CZ-PrNML
005      
20241016081847.0
007      
ta
008      
241008e20240920nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/PRBM.S461742 $2 doi
035    __
$a (PubMed)39318855
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Bocek, Jonas $u Department of Psychiatry, University Hospital Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000305297731
245    10
$a Anxiety in Patients with Post-COVID Syndrome: Associated Factors / $c J. Bocek, D. Kamaradova Koncelikova, J. Vanek, K. Latalova, S. Genzor, J. Mizera
520    9_
$a INTRODUCTION: The term "post-COVID-19 syndrome" describes a range of symptoms persisting beyond the acute phase of the disease. These symptoms predominantly include fatigue, muscle pain, shortness of breath, and psychological issues. Research additionally suggests the possibility of long-term neurological and psychiatric impairment associated with COVID-19. METHODOLOGY: The study included patients who visited the post-COVID outpatient clinic between April 2020 and June 2022. The examination included the detailed history taking, including the COVID-19 course, posteroanterior chest X-ray and pulmonary function tests. Anxiety level was assessed using the Beck Anxiety Inventory (BAI). The relationship between anxiety, demographic data, and course of the disease, need for hospital admission during the acute phase, oxygen therapy, post-inflammatory changes on the chest X-ray and lung function parameters was investigated. RESULTS: This study included 1756 patients who experienced COVID-19 and visited a post-COVID outpatient clinic. The majority of individuals experienced a mild form of the infection. The results showed that younger age and female gender were associated with significantly higher anxiety scores. Inpatients had lower BAI values than those who were not hospitalized during acute phase. Patients with post-inflammatory changes on chest X-ray had surprisingly lower BAI values. Lower values of FEV1 (forced expiratory volume in 1 second), DLCO (diffusing capacity of the lungs for carbon monoxide), and KCO (carbon monoxide transfer coefficient) were associated with significantly higher BAI values. Female gender was associated with higher levels of anxiety. In contrast, higher FEV1 values reduced the risk of a pathological level of anxiety. CONCLUSION: In our study, the influence of age, gender, inpatient care during the acute phase of infection, the presence of post-inflammatory changes on the chest diagram and selected parameters of lung function (FEV1, DLCO, and KCO) were shown to be important factors in the assessment of anxiety symptoms in post-COVID patients.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kamaradova Koncelikova, Dana $u Department of Psychiatry, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Vanek, Jakub $u Department of Psychiatry, University Hospital Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000328331736 $7 xx0230065
700    1_
$a Latalova, Klara $u Department of Psychiatry, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Genzor, Samuel $u Department of Respiratory Medicine and Tuberculosis, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Mizera, Jan $u Department of Respiratory Medicine and Tuberculosis, University Hospital Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000289524243 $7 xx0238803
773    0_
$w MED00198786 $t Psychology research and behavior management $x 1179-1578 $g Roč. 17 (20240920), s. 3255-3265
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39318855 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241008 $b ABA008
991    __
$a 20241016081842 $b ABA008
999    __
$a ok $b bmc $g 2196372 $s 1229729
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 17 $c - $d 3255-3265 $e 20240920 $i 1179-1578 $m Psychology research and behavior management $n Psychol Res Behav Manag $x MED00198786
LZP    __
$a Pubmed-20241008

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...